- Home
- NERV vs GWAV Comparison
NERV vs GWAV Comparison
Compare NERV & GWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- GWAV
- Stock Information
- Founded
- NERV 2007
- GWAV 2002
- Country
- NERV United States
- GWAV United States
- Employees
- NERV N/A
- GWAV N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- GWAV Packaged Foods
- Sector
- NERV Health Care
- GWAV Consumer Staples
- Exchange
- NERV Nasdaq
- GWAV Nasdaq
- Market Cap
- NERV 12.4M
- GWAV 12.6M
- IPO Year
- NERV 2014
- GWAV N/A
- Fundamental
- Price
- NERV $1.84
- GWAV $0.21
- Analyst Decision
- NERV Hold
- GWAV
- Analyst Count
- NERV 1
- GWAV 0
- Target Price
- NERV $5.00
- GWAV N/A
- AVG Volume (30 Days)
- NERV 15.2K
- GWAV 1.7M
- Earning Date
- NERV 08-05-2025
- GWAV 06-13-2025
- Dividend Yield
- NERV N/A
- GWAV N/A
- EPS Growth
- NERV N/A
- GWAV N/A
- EPS
- NERV 0.83
- GWAV N/A
- Revenue
- NERV N/A
- GWAV $33,315,859.00
- Revenue This Year
- NERV N/A
- GWAV N/A
- Revenue Next Year
- NERV N/A
- GWAV N/A
- P/E Ratio
- NERV $2.23
- GWAV N/A
- Revenue Growth
- NERV N/A
- GWAV N/A
- 52 Week Low
- NERV $1.15
- GWAV $0.12
- 52 Week High
- NERV $3.69
- GWAV $3.88
- Technical
- Relative Strength Index (RSI)
- NERV 65.83
- GWAV 53.75
- Support Level
- NERV $1.75
- GWAV $0.18
- Resistance Level
- NERV $1.90
- GWAV $0.23
- Average True Range (ATR)
- NERV 0.12
- GWAV 0.02
- MACD
- NERV 0.04
- GWAV 0.00
- Stochastic Oscillator
- NERV 90.00
- GWAV 63.33
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About GWAV Greenwave Technology Solutions Inc.
Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.